These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2198918)

  • 1. The physiological and clinical effects of progesterone inhibition with mifepristone (RU 486) in the second trimester.
    Hill NC; Selinger M; Ferguson J; López Bernal A; Mackenzie IZ
    Br J Obstet Gynaecol; 1990 Jun; 97(6):487-92. PubMed ID: 2198918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone inhibition in mid-trimester termination of pregnancy: physiological and clinical effects.
    Selinger M; Mackenzie IZ; Gillmer MD; Phipps SL; Ferguson J
    Br J Obstet Gynaecol; 1987 Dec; 94(12):1218-22. PubMed ID: 3322376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
    Swahn ML; Bygdeman M
    Br J Obstet Gynaecol; 1988 Feb; 95(2):126-34. PubMed ID: 3349002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.
    Ho PC; Ma HK
    Contraception; 1993 Feb; 47(2):123-9. PubMed ID: 8449013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The placental transfer of mifepristone (RU 486) during the second trimester and its influence upon maternal and fetal steroid concentrations.
    Hill NC; Selinger M; Ferguson J; MacKenzie IZ
    Br J Obstet Gynaecol; 1990 May; 97(5):406-11. PubMed ID: 2372525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of the anti-progestin mifepristone (RU 486) on plasma prostaglandin metabolite levels in early pregnancy and its influence on pregnancy termination.
    Hill NC; López Bernal A; Ferguson J; MacKenzie IZ
    Acta Obstet Gynecol Scand; 1990; 69(4):321-5. PubMed ID: 2244464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplacental passage of mifepristone and its influence on maternal and fetal steroid concentrations in the second trimester of pregnancy.
    Hill NC; Selinger M; Ferguson J; MacKenzie IZ
    Hum Reprod; 1991 Mar; 6(3):458-62. PubMed ID: 1955558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment of the primigravid uterine cervix with mifepristone 30 h prior to termination of pregnancy: a double blind study.
    Cohn M; Stewart P
    Br J Obstet Gynaecol; 1991 Aug; 98(8):778-82. PubMed ID: 1911585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.
    Bygdeman M; Swahn ML; Gemzell-Danielsson K; Gottlieb C
    Hum Reprod; 1994 Jun; 9 Suppl 1():121-5. PubMed ID: 7962458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of mifepristone prior to prostaglandin-induced mid-trimester abortion.
    Urquhart DR; Templeton AA
    Hum Reprod; 1990 Oct; 5(7):883-6. PubMed ID: 2266162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry of myometrial contractility.
    Egarter CH; Husslein P
    Baillieres Clin Obstet Gynaecol; 1992 Dec; 6(4):755-69. PubMed ID: 1335853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion.
    Durlot F; Dubois C; Brunerie J; Frydman R
    Hum Reprod; 1988 Jul; 3(5):583-4. PubMed ID: 3170699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mifepristone (RU 486) for induced abortion.
    Grimes DA
    Womens Health Issues; 1993; 3(3):171-5. PubMed ID: 8274873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
    Bygdeman M; Swahn ML
    Contraception; 1985 Jul; 32(1):45-51. PubMed ID: 4053605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
    Swahn ML; Bygdeman M
    Acta Obstet Gynecol Scand; 1989; 68(4):293-300. PubMed ID: 2694744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the effect of mifepristone (antiprogesterone) followed by prostaglandin on uterine activity and fetal heart rate in patients having a termination of pregnancy.
    Pulkkinen MO; Piiroinen O; Vainikka J
    Arch Gynecol Obstet; 1989; 244(2):75-8. PubMed ID: 2712600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin F2 alpha, oxytocin, and uterine activation in hypertonic saline-induced abortions.
    Fuchs AR; Rasmussen AB; Rehnström J; Toth M
    Am J Obstet Gynecol; 1984 Sep; 150(1):27-32. PubMed ID: 6476024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mifepristone on dilatation of the pregnant and non-pregnant cervix.
    Gupta JK; Johnson N
    Lancet; 1990 May; 335(8700):1238-40. PubMed ID: 1971320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.